Vitamin D status and 5-year changes in urine albumin creatinine ratio and parathyroid hormone in a general population

被引:21
作者
Skaaby, Tea [1 ]
Husemoen, Lise Lotte Nystrup [1 ]
Pisinger, Charlotta [1 ]
Jorgensen, Torben [1 ,2 ,3 ]
Thuesen, Betina Heinsbaek [1 ]
Rasmussen, Knud [4 ]
Fenger, Mogens [5 ]
Rossing, Peter [6 ,7 ,8 ]
Linneberg, Allan [1 ]
机构
[1] Glostrup Cty Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark
[2] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark
[3] Aalborg Univ, Fac Med, Aalborg, Denmark
[4] Roskilde Univ Hosp, Dept Med, Roskilde, Denmark
[5] Univ Copenhagen, Hvidovre Hosp, Dept Clin Biochem, DK-2650 Hvidovre, Denmark
[6] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
[7] Univ Copenhagen, Copenhagen, Denmark
[8] Univ Aarhus, Aarhus, Denmark
关键词
Albuminuria; Parathyroid hormone; Prospective; Urine albumin creatinine ratio; Vitamin D; 25-HYDROXYVITAMIN-D LEVELS; SERUM 25(OH)D; SPOT URINE; RISK; MICROALBUMINURIA; ASSOCIATION; METABOLISM; STABILITY; ASSAYS; BLOOD;
D O I
10.1007/s12020-013-9887-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vitamin D is associated with cardiovascular disease and renal function but the mechanisms are as yet unexplained. Microalbuminuria is associated with a higher risk of kidney function loss, cardiovascular disease, and mortality. Parathyroid hormone is a predictor of cardiovascular mortality and negatively correlated with glomerular filtration rate. We investigated the association between vitamin D status and 5-year changes in urine albumin creatinine ratio (UACR) and parathyroid hormone (PTH). A random sample of 6,784 individuals aged 30-60 years from a general population participated in the Inter99 study in 1999-2001. Vitamin D (serum-25-hydroxyvitamin D) was measured at baseline by high-performance liquid chromatography. UACR and PTH were measured at baseline and follow-up. Increased UACR was defined as UACR > 4.0 mg/g reflecting the upper quartile at baseline. We included 4,330 individuals who participated at 5-year follow-up. In multivariable linear regression analysis, a 10-nmol/l higher baseline level of vitamin D was associated with a 5-year decrease in UACR by 0.92 % (95 % confidence interval, CI 0.13, 1.71). In multivariable logistic regression analysis, the odds ratio of developing increased UACR during follow-up was 0.96 (95 % CI 0.92, 0.98) per 10 nmol/l higher baseline vitamin D level. We found a significant inverse cross-sectional (p < 0.0001) but no prospective association (p = 0.6) between baseline vitamin D status and parathyroid hormone. We found low vitamin D status to be a predictor of long-term development of increased UACR. It remains to be proven whether vitamin D deficiency is a causal and reversible factor in the development of albuminuria.
引用
收藏
页码:473 / 480
页数:8
相关论文
共 37 条
[1]   Definition of microalbuminuria in first-morning and random spot urine in diabetic patients [J].
Babazono, T ;
Takahashi, C ;
Iwamoto, Y .
DIABETES CARE, 2004, 27 (07) :1838-1839
[2]   The relation of serum 25-hydroxyvitamin-D levels with severity of obstructive sleep apnea and glucose metabolism abnormalities [J].
Bozkurt, N. Colak ;
Cakal, E. ;
Sahin, M. ;
Ozkaya, E. Cakir ;
Firat, H. ;
Delibasi, T. .
ENDOCRINE, 2012, 41 (03) :518-525
[3]   Measurement of vitamin D metabolites: an international perspective on methodology and clinical interpretation [J].
Carter, GD ;
Carter, CR ;
Gunter, E ;
Jones, J ;
Jones, G ;
Makin, HLJ ;
Sufi, S .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 89-90 (1-5) :467-471
[4]   25-Hydroxyvitamin D Assays: The Quest For Accuracy [J].
Carter, Graham D. .
CLINICAL CHEMISTRY, 2009, 55 (07) :1300-1302
[5]   Vitamin D and diabetes mellitus [J].
Danescu, Liviu G. ;
Levy, Shiri ;
Levy, Joseph .
ENDOCRINE, 2009, 35 (01) :11-17
[6]   25-hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III) [J].
de Boer, Ian H. ;
Ioannou, George N. ;
Kestenbaum, Bryan ;
Brunzell, John D. ;
Weiss, Noel S. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 50 (01) :69-77
[7]   Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy [J].
de Zeeuw, D ;
Remuzzi, G ;
Parving, HH ;
Keane, WF ;
Zhang, ZX ;
Shahinfar, S ;
Snapinn, S ;
Cooper, ME ;
Mitch, WE ;
Brenner, BM .
CIRCULATION, 2004, 110 (08) :921-927
[8]   Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial [J].
de Zeeuw, Dick ;
Agarwal, Rajiv ;
Amdahl, Michael ;
Audhya, Paul ;
Coyne, Daniel ;
Garimella, Tushar ;
Parving, Hans-Henrik ;
Pritchett, Yili ;
Remuzzi, Giuseppe ;
Ritz, Eberhard ;
Andress, Dennis .
LANCET, 2010, 376 (9752) :1543-1551
[9]   On the evolving nature of understanding dialysis-related disorders [J].
Eknoyan, G ;
Lindberg, JS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (04) :S1-S3
[10]   Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC:: need for assay-specific decision limits and metabolite-specific assays [J].
Glendenning, P ;
Taranto, M ;
Noble, JM ;
Musk, AA ;
Hammond, C ;
Goldswain, PR ;
Fraser, WD ;
Vasikaran, SD .
ANNALS OF CLINICAL BIOCHEMISTRY, 2006, 43 :23-30